GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) » Definitions » Total Long-Term Liabilities

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) Total Long-Term Liabilities : TND0.00 Mil (As of . 20)


View and export this data going back to 2001. Start your Free Trial

What is Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Long-Term Liabilities for the quarter that ended in . 20 was TND0.00 Mil.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Long-Term Liabilities Historical Data

The historical data trend for Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Long-Term Liabilities Chart

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Annual Data
Trend
Total Long-Term Liabilities

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Semi-Annual Data
Total Long-Term Liabilities

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Societe des Industries Pharmaceutiques de Tunisie-S I PHA T's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Societe des Industries Pharmaceutiques de Tunisie-S I PHA T (XTUN:SIPHA) » Definitions » Total Long-Term Liabilities
Comparable Companies
BIEI BOM:524516 TSXV:CIP.H BOM:531686 PTXTQ BOM:524606 XCNQ:WRW NSE:PARABDRUGS BOM:533157 INQD XCNQ:CANA BOM:524314 ACCA BOM:511523 BOM:531541 XCNQ:WLLW BKIT BOM:524768 BOM:540359 BOM:524632
Traded in Other Exchanges
N/A
Address
Fondouk Choucha, Ben Arous, TUN, 2013
Website
http://www.siphat.rns.tn
Societe des Industries Pharmaceutiques de Tunisie-S I PHA T is a Tunisia-based company mainly engaged in manufacturing and distributing medicines and drugs. The company also has its own research and development process to develop generic drugs. It offers pharmaceutical, dietary, hygiene, and cosmetic products in dry, liquid and pasty forms.

Societe des Industries Pharmaceutiques de Tunisie-S I PHA T Headlines

No Headlines